TY  - GEN
AU  - Kaufman,Bella
AU  - Shapira-Frommer,Ronnie
AU  - Schmutzler,Rita K
AU  - Audeh,M William
AU  - Friedlander,Michael
AU  - Balmaña,Judith
AU  - Mitchell,Gillian
AU  - Fried,Georgeta
AU  - Stemmer,Salomon M
AU  - Hubert,Ayala
AU  - Rosengarten,Ora
AU  - Steiner,Mariana
AU  - Loman,Niklas
AU  - Bowen,Karin
AU  - Fielding,Anitra
AU  - Domchek,Susan M
TI  - Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation
SN  - 1527-7755
PY  - 2015///0316
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Germ-Line Mutation
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Ovarian Neoplasms
KW  - Pancreatic Neoplasms
KW  - Phthalazines
KW  - Piperazines
KW  - Prospective Studies
KW  - Prostatic Neoplasms
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1200/JCO.2014.56.2728
ER  -